ARL2BP and central nervous system cancer: Karimzadeh et al. found that the expression level of EBV-BART1-3p in central nervous system tumor specimens with positive EBV was significantly higher than that in control specimens, and the change in miR-BART1-3p expression was involved in the development of glioma cells [16].